No Data
No Data
Realcan Pharmaceutical Group (SZSE:002589) Stock Falls 10% in Past Week as Five-year Earnings and Shareholder Returns Continue Downward Trend
Realcan Pharmaceutical Group (SZSE:002589) Earnings and Shareholder Returns Have Been Trending Downwards for the Last Five Years, but the Stock Soars 12% This Past Week
Realcan Pharmaceutical Group's (SZSE:002589) Solid Earnings Have Been Accounted For Conservatively
Benign Growth For Realcan Pharmaceutical Group Co., Ltd. (SZSE:002589) Underpins Stock's 30% Plummet
Further Weakness as Realcan Pharmaceutical Group (SZSE:002589) Drops 12% This Week, Taking Five-year Losses to 60%
Does Realcan Pharmaceutical Group (SZSE:002589) Have A Healthy Balance Sheet?